Evaluation of circulating tumor cells in stage III colorectal cancer patients under three or six months of adjuvant therapy.

被引:0
|
作者
Messaritakis, Ippokratis
Koulouridi, Asimina
Sfakianaki, Maria
Vogiatzoglou, Konstantinos
Gouvas, Nikolaos
Tsiaousis, Ioannis
Athanasakis, Elias
Xynos, Evangelos
Sougklakos, Ioannis
Boukovinas, Ioannis
机构
[1] Univ Crete, Sch Med, Lab Translat Oncol, Iraklion, Greece
[2] Univ Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
[3] Univ Crete, Dept Translat Oncol, Iraklion, Greece
[4] Univ Cyprus, Nikosia, Cyprus
[5] Univ Crete, Iraklion, Greece
[6] Univ Hosp Heraklion, Iraklion, Greece
[7] Creta Interclin Hosp, Iraklion, Greece
[8] Univ Heraklion, Iraklion, Greece
[9] Bioclin Thessaloniki, Thessaloniki, Greece
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15601
引用
收藏
页码:E15601 / E15601
页数:1
相关论文
共 50 条
  • [1] Detection of Circulating Tumor Cells and Microbial DNA Fragments in Stage III Colorectal Cancer Patients under Three versus Six Months of Adjuvant Treatment
    Koulouridi, Asimina
    Messaritakis, Ippokratis
    Theodorakis, Emmanouil
    Chondrozoumaki, Maria
    Sfakianaki, Maria
    Gouvas, Nikolaos
    Tsiaoussis, John
    Mavroudis, Dimitrios
    Tzardi, Maria
    Souglakos, John
    CANCERS, 2021, 13 (14)
  • [2] Three vs. six months of adjuvant therapy in stage III colon cancer
    Fahrig, Luca
    Zander, Thomas
    Alakus, Hakan
    ONKOLOGIE, 2022, 28 (10): : 937 - 939
  • [3] Adjuvant chemotherapy for patients with stage III colon cancer, three months vs six months. A single centre experience
    Martin-Montalvo, G.
    Martinez Perez, D.
    Ruiz-Gutierrez, I.
    Alameda, M.
    Rueda-Lara, A.
    Pena, J.
    Jimenez-Bou, D.
    Vinal, D.
    Garcia-Cuesta, J.
    Pedregosa Barbas, J.
    Rodriguez-Salas, N.
    Feliu, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S114 - S114
  • [4] Adjuvant therapy for stage II and III colorectal cancer
    de Gramont, Aimery
    Tournigand, Christophe
    Andre, Thierry
    Larsen, Annette K.
    Louvet, Christophe
    SEMINARS IN ONCOLOGY, 2007, 34 (02) : S37 - S40
  • [5] Circulating tumor DNA analysis: potential to revise adjuvant therapy for stage II colorectal cancer
    Zhu, Ning
    Hu, Hanguang
    Yuan, Ying
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [6] Circulating tumor DNA analysis: potential to revise adjuvant therapy for stage II colorectal cancer
    Ning Zhu
    Hanguang Hu
    Ying Yuan
    Signal Transduction and Targeted Therapy, 7
  • [7] Probability of detection of circulating tumor cells in colorectal cancer stage III-IV
    Nikipelova, Elena Alekseevna
    Kit, Oleg Ivanovich
    Novikova, Inna Arnoldovna
    Maksimov, Aleksey Yurievich
    Bakhtin, Andrey Vladimirovich
    Nistratova, Olesta Vladimirovna
    Ulianova, Elena Petrovna
    Anapalian, Valerie
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer
    Sotelo, M. J.
    Sastre, J.
    Maestro, M. L.
    Veganzones, S.
    Vieitez, J. M.
    Alonso, V.
    Gravalos, C.
    Escudero, P.
    Vera, R.
    Aranda, E.
    Garcia-Alfonso, P.
    Gallego-Plazas, J.
    Lopez, C.
    Pericay, C.
    Arrivi, A.
    Vicente, P.
    Ballesteros, P.
    Elez, E.
    Lopez-Ladron, A.
    Diaz-Rubio, E.
    ANNALS OF ONCOLOGY, 2015, 26 (03) : 535 - 541
  • [9] Circulating tumor cells in colorectal cancer patients
    Torino, Francesco
    Bonmassar, Enzo
    Bonmassar, Laura
    De Vecchis, Liana
    Barnabei, Agnese
    Zuppi, Cecilia
    Capoluongo, Ettore
    Aquino, Angelo
    CANCER TREATMENT REVIEWS, 2013, 39 (07) : 759 - 772
  • [10] Evaluation of cell surface vimentin positive circulating tumor cells as a prognostic biomarker for stage III/IV colorectal cancer
    Jiazi Yu
    Mian Yang
    Tao Peng
    Yelei Liu
    Yuepeng Cao
    Scientific Reports, 13